CD4 and lung cancer: Arasanz et al. [60] found that CD4+CD28− T cells in the peripheral blood of lung cancer patients with HPD were amplified after PD-1 treatment, and high tumor growth dynamics scores were associated with the presence of CD4+CD28− T-cell subsets in patients with HPD.